Arnaud Carpentier

1.3k total citations
25 papers, 926 citations indexed

About

Arnaud Carpentier is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Arnaud Carpentier has authored 25 papers receiving a total of 926 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Hepatology, 13 papers in Epidemiology and 6 papers in Surgery. Recurrent topics in Arnaud Carpentier's work include Hepatitis C virus research (15 papers), Liver Disease Diagnosis and Treatment (10 papers) and Hepatitis B Virus Studies (8 papers). Arnaud Carpentier is often cited by papers focused on Hepatitis C virus research (15 papers), Liver Disease Diagnosis and Treatment (10 papers) and Hepatitis B Virus Studies (8 papers). Arnaud Carpentier collaborates with scholars based in France, Germany and United States. Arnaud Carpentier's co-authors include Arielle R. Rosenberg, Céline Hernandez, T. Jake Liang, Katrin Kaehlcke, Robert V. Farese, Mélanie Ott, Charles Harris, Eva Herker, Yuchen Xia and Ila Nimgaonkar and has published in prestigious journals such as Journal of Clinical Investigation, Nature Medicine and Gastroenterology.

In The Last Decade

Arnaud Carpentier

25 papers receiving 919 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Arnaud Carpentier France 12 505 382 254 140 119 25 926
Kyoji Moriya Japan 7 620 1.2× 652 1.7× 230 0.9× 45 0.3× 41 0.3× 12 953
Grégory Camus United States 17 455 0.9× 490 1.3× 270 1.1× 28 0.2× 116 1.0× 32 1.1k
C Bréchot France 14 1.4k 2.8× 1.2k 3.2× 275 1.1× 72 0.5× 86 0.7× 36 1.7k
Sylvie Rumin France 7 875 1.7× 864 2.3× 322 1.3× 109 0.8× 22 0.2× 9 1.5k
Daniel J. Felmlee United Kingdom 17 818 1.6× 735 1.9× 129 0.5× 83 0.6× 20 0.2× 34 1.0k
Kung‐Chia Young Taiwan 10 291 0.6× 290 0.8× 153 0.6× 65 0.5× 15 0.1× 16 630
Zhongping Duan China 18 552 1.1× 692 1.8× 337 1.3× 52 0.4× 9 0.1× 45 1.1k
A Uhrig Germany 8 395 0.8× 319 0.8× 163 0.6× 182 1.3× 13 0.1× 10 1.0k
Reina Sasaki Japan 18 547 1.1× 439 1.1× 401 1.6× 78 0.6× 6 0.1× 87 1.2k
Shirish Paranjpe United States 19 454 0.9× 284 0.7× 254 1.0× 341 2.4× 23 0.2× 30 963

Countries citing papers authored by Arnaud Carpentier

Since Specialization
Citations

This map shows the geographic impact of Arnaud Carpentier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arnaud Carpentier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arnaud Carpentier more than expected).

Fields of papers citing papers by Arnaud Carpentier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arnaud Carpentier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arnaud Carpentier. The network helps show where Arnaud Carpentier may publish in the future.

Co-authorship network of co-authors of Arnaud Carpentier

This figure shows the co-authorship network connecting the top 25 collaborators of Arnaud Carpentier. A scholar is included among the top collaborators of Arnaud Carpentier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arnaud Carpentier. Arnaud Carpentier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Carpentier, Arnaud. (2024). Cell Culture Models for Hepatitis B and D Viruses Infection: Old Challenges, New Developments and Future Strategies. Viruses. 16(5). 716–716. 1 indexed citations
2.
Carpentier, Arnaud, et al.. (2024). Host-targeting antivirals for chronic viral infections of the liver. Antiviral Research. 234. 106062–106062. 3 indexed citations
3.
Vondran, Florian W. R., et al.. (2023). Hepatitis D virus infection, innate immune response and antiviral treatments in stem cell‐derived hepatocytes. Liver International. 43(10). 2116–2129. 5 indexed citations
4.
Groitl, Peter, Chunkyu Ko, Peter A. Zimmerman, et al.. (2023). SUMO Modification of Hepatitis B Virus Core Mediates Nuclear Entry, Promyelocytic Leukemia Nuclear Body Association, and Efficient Formation of Covalently Closed Circular DNA. Microbiology Spectrum. 11(3). e0044623–e0044623. 13 indexed citations
5.
Carpentier, Arnaud, Julie Sheldon, Florian W. R. Vondran, Richard J. P. Brown, & Thomas Pietschmann. (2020). Efficient acute and chronic infection of stem cell-derived hepatocytes by hepatitis C virus. Gut. 69(9). 1659–1666. 15 indexed citations
6.
Vièyres, Gabrielle, et al.. (2020). The ATGL lipase cooperates with ABHD5 to mobilize lipids for hepatitis C virus assembly. PLoS Pathogens. 16(6). e1008554–e1008554. 30 indexed citations
7.
Hernandez, Céline, Étienne Blanc, Véronique Pène, et al.. (2019). Impact of hepatitis C virus and alcohol, alone and combined, on the unfolded protein response in primary human hepatocytes. Biochimie. 168. 17–27. 2 indexed citations
8.
Carpentier, Arnaud, Ila Nimgaonkar, Virginia Chu, et al.. (2016). Hepatic differentiation of human pluripotent stem cells in miniaturized format suitable for high-throughput screen. Stem Cell Research. 16(3). 640–650. 61 indexed citations
9.
Xia, Yuchen, Arnaud Carpentier, Xiaoming Cheng, et al.. (2016). Human stem cell-derived hepatocytes as a model for hepatitis B virus infection, spreading and virus-host interactions. Journal of Hepatology. 66(3). 494–503. 103 indexed citations
10.
Carpentier, Arnaud & T. Jake Liang. (2015). Transplantation d’hépatocytes humains dérivés de cellules souches dans le foie de souris. médecine/sciences. 31(3). 256–259. 3 indexed citations
11.
Carpentier, Arnaud, Abeba Tesfaye, Virginia Chu, et al.. (2014). Engrafted human stem cell–derived hepatocytes establish an infectious HCV murine model. Journal of Clinical Investigation. 124(11). 4953–4964. 102 indexed citations
12.
Carpentier, Arnaud, et al.. (2012). Update on counterfeit antibiotics worldwide; Public health risks. Médecine et Maladies Infectieuses. 42(6). 247–255. 80 indexed citations
13.
Herker, Eva, Charles Harris, Céline Hernandez, et al.. (2010). Efficient hepatitis C virus particle formation requires diacylglycerol acyltransferase-1. Nature Medicine. 16(11). 1295–1298. 270 indexed citations
14.
Podevin, Philippe, Arnaud Carpentier, Véronique Pène, et al.. (2010). Production of Infectious Hepatitis C Virus in Primary Cultures of Human Adult Hepatocytes. Gastroenterology. 139(4). 1355–1364.e6. 121 indexed citations
15.
Rosenberg, Arielle R., Arnaud Carpentier, & Philippe Podevin. (2010). Enfin un modèle de culture du virus de l’hépatite C adapté aux hépatocytes humains primaires !. médecine/sciences. 26(12). 1012–1014. 1 indexed citations
16.
Miroux, Céline, Olivier Moralès, Arnaud Carpentier, et al.. (2009). Inhibitory Effects of Cyclosporine on Human Regulatory T Cells In Vitro. Transplantation Proceedings. 41(8). 3371–3374. 46 indexed citations
17.
Carpentier, Arnaud, Filoména Conti, Fabien Stenard, et al.. (2009). Increased Expression of Regulatory Tr1 Cells in Recurrent Hepatitis C after Liver Transplantation. American Journal of Transplantation. 9(9). 2102–2112. 34 indexed citations
18.
Carpentier, Arnaud, Filoména Conti, Matthieu Carrière, et al.. (2009). Analysis of gene transcription in sera during chronic hepatitis C infection. Journal of Medical Virology. 81(3). 473–480. 8 indexed citations
19.
20.
Carpentier, Arnaud, et al.. (1996). Normal human polyclonal immunoglobulins delay xenograft rejection through distinct F(ab')2 and Fc mediated mechanisms.. PubMed. 28(2). 853–4. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026